General anesthesia
Conditions
Interventions
Experimental group :Fosphopropofol
Control group:Etomidate
Control group: cyclopofol
Sponsors
The Second Affiliated Hospital of Zhengzhou University
Eligibility
Sex/Gender
All
Age
65 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. All patients were diagnosed with ureteral stones through X-ray or ultrasound examination, and the disease was unilateral; 2. ASA level I - II; 3. Age>=65 years; 4.BMI < 28 kg /m^2
Exclusion criteria
Exclusion criteria: 1. Allergic to drugs used in this study; 2. Abnormal adrenal cortical function; 3. Severe dysfunction of heart, brain, lung, liver, kidney and other organs before operation; 4. Long-term use of analgesic and sedative drugs.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Heart rate;systolic blood pressure;diastolic blood pressure;Mean arterial pressure;BIS value; | — |
Secondary
| Measure | Time frame |
|---|---|
| The time from intravenous injection of propofol disodium, cyclopropofol or etomidate to the start of pumping propofol (BIS value reached 50% to start pumping).;The dosage of propofol and remifentanil was maintained during the operation.; | — |
Countries
China
Contacts
Public ContactXia Li
The Second Affiliated Hospital of Zhengzhou University
Outcome results
None listed